Nalog, Haniesa .
HRN: 27-45-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2025
CEFUROXIME 1.5GM (VIAL)
07/08/2025
07/09/2025
IV
1.5grams
Q8, 2 More Doses
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes